These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

162 related articles for article (PubMed ID: 15612335)

  • 1. Adverse selection and the challenges to stand-alone prescription drug insurance.
    Pauly MV; Zeng Y
    Front Health Policy Res; 2004; 7():55-74. PubMed ID: 15612335
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Purchasing Medicare prescription drug benefits: a new proposal.
    Etheredge L
    Health Aff (Millwood); 1999; 18(4):7-19. PubMed ID: 10425838
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prescription-drug coverage for medicare beneficiaries.
    Iglehart JK
    N Engl J Med; 2003 Sep; 349(10):923-5. PubMed ID: 12954738
    [No Abstract]   [Full Text] [Related]  

  • 4. Perverse incentives in the Medicare prescription drug benefit.
    McAdams D; Schwarz M
    Inquiry; 2007; 44(2):157-66. PubMed ID: 17850042
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The relationship between health plan advertising and market incentives: evidence of risk-selective behavior.
    Mehrotra A; Grier S; Dudley RA
    Health Aff (Millwood); 2006; 25(3):759-65. PubMed ID: 16684741
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The effect of supplemental medical and prescription drug coverage on health care spending for Medicare beneficiaries with cancer.
    Erten MZ; Davidoff AJ; Zuckerman IH; Shaffer T; Dougherty JS; Ke X; Stuart B
    Value Health; 2014; 17(1):15-21. PubMed ID: 24438713
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Impact of generosity level of outpatient prescription drug coverage on prescription drug events and expenditure among older persons.
    Artz MB; Hadsall RS; Schondelmeyer SW
    Am J Public Health; 2002 Aug; 92(8):1257-63. PubMed ID: 12144981
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Estimating the effects of prescription drug coverage for Medicare beneficiaries.
    Shea DG; Terza JV; Stuart BC; Briesacher B
    Health Serv Res; 2007 Jun; 42(3 Pt 1):933-49. PubMed ID: 17489897
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prescription drug coverage, utilization, and spending among Medicare beneficiaries.
    Davis M; Poisal J; Chulis G; Zarabozo C; Cooper B
    Health Aff (Millwood); 1999; 18(1):231-43. PubMed ID: 9926660
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insurance coverage for prescription drugs: effects on use and expenditures in the Medicare population.
    Lillard LA; Rogowski J; Kington R
    Med Care; 1999 Sep; 37(9):926-36. PubMed ID: 10493470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of prescription coverage on hospital and physician costs: a case study of medicare beneficiaries with chronic obstructive pulmonary disease.
    Stuart B; Doshi JA; Briesacher B; Wrobel MV; Baysac F
    Clin Ther; 2004 Oct; 26(10):1688-99. PubMed ID: 15598486
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The interaction of partial public insurance programs and residual private insurance markets: evidence from the US Medicare program.
    Finkelstein A
    J Health Econ; 2004 Jan; 23(1):1-24. PubMed ID: 15154686
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Falling into the doughnut hole: drug spending among beneficiaries with end-stage renal disease under Medicare Part D plans.
    Patel UD; Davis MM
    J Am Soc Nephrol; 2006 Sep; 17(9):2546-53. PubMed ID: 16855016
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A first look at the new Medicare prescription drug plans.
    Frakt AB; Pizer SD
    Health Aff (Millwood); 2006; 25(4):W252-61. PubMed ID: 16720588
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Medicare beneficiaries and drug coverage.
    Poisal JA; Chulis GS
    Health Aff (Millwood); 2000; 19(2):248-56. PubMed ID: 10718039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Medicare prescription drug coverage: consumer information and preferences.
    Winter J; Balza R; Caro F; Heiss F; Jun BH; Matzkin R; McFadden D
    Proc Natl Acad Sci U S A; 2006 May; 103(20):7929-34. PubMed ID: 16682629
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Medicare program; Medicare prescription drug benefit. Final rule.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2005 Jan; 70(18):4193-585. PubMed ID: 15678603
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Savings needed to fund health insurance and health care expenses in retirement: findings from a simulation model.
    Fronstin P; Salisbury D; VanDerhei J
    EBRI Issue Brief; 2008 May; (317):1-2, 4-27. PubMed ID: 18630312
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The Medicare prescription drug proposals and health insurance risk.
    Gencarelli DM
    NHPF Issue Brief; 2003 Sep; (793):1-12. PubMed ID: 12964574
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prescription drugs: issues of cost, coverage, and quality.
    Copeland C
    EBRI Issue Brief; 1999 Apr; (208):1-21. PubMed ID: 10539445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.